In Vitro & In Vivo Diagnostic Substances Stocks
15 in vitro & in vivo diagnostic substances stocks with fundamental analysis, valuation charts, and SEC filing data. Industry median P/E is 36.1, median ROIC -27.5%, and combined market cap of $59.0B.
IDXX — IDEXX LABORATORIES INC /DE
IDEXX Laboratories develops, manufactures, and distributes diagnostic products and services across three primary segments: Companion Animal Group (CAG), Water quality products, and Livestock, Poultry .
LNTH — Lantheus Holdings, Inc.
Lantheus is a radiopharmaceutical-focused company that develops and commercializes diagnostic and therapeutic products organized into three categories: Radiopharmaceutical Oncology (including PYLARIFY.